Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand

Health Economics Review

Table 3 Base-case utility values

Parameters	Value	Sources
One-year decision tree
*Ticagrelor*
No event	0.873	PLATO [7], Nikolic [8]
Non-fatal MI	0.811	PLATO [7], Nikolic [8]
Non-fatal stroke	0.735	PLATO [7], Nikolic [8]
Death any cause	0.247	PLATO [7], Nikolic [8]
*Clopidogrel*
No event	0.876	PLATO [7], Nikolic [8]
Non-fatal MI	0.814	PLATO [7], Nikolic [8]
Non-fatal stroke	0.738	PLATO [7], Nikolic [8]
Death any cause	0.250	PLATO [7], Nikolic [8]
Markov model ^a
No event aged less than 70 years	0.875	PLATO [7], Nikolic [8]
No event aged 70–79 years	0.843	PLATO [7], Nikolic [8]
No event aged over 79 years	0.781	PLATO [7], Nikolic [8]
Annual utility decrement MI 1^st year Markov model and 2^nd year onward	0.147	Tamteeranon [15]
Annual utility decrement stroke 1^st year Markov model and 2^nd year onward	0.226	Tamteeranon [15]

ISSN: 2191-1991